Imfinzi (durvalumab) - AstraZeneca
|
Tecentriq (atezolizumab) - Roche
|
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
|
Jemperli (dostarlimab-gxly) - GSK
|
Zynyz (retifanlimab-dlwr) - Incyte
|
Bavencio (avelumab) - EMD Serono
|
Keytruda (pembrolizumab) - Merck (MSD)
|
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
|
Libtayo (cemiplimab-rwlc) - Regeneron
|
Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology
|